RxDoctor Payments Data

Sean McCain, MD

Family Medicine · Marion, ILNPI 1629050307

Payments from drug & device makers

$1,302in general payments, 2019–2025

Across 61 payments — averaging $21.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corcept Therapeutics$370
  • AbbVie$255
  • AstraZeneca$164
  • Novo Nordisk$82
  • Xeris Pharmaceuticals, Inc.$71
  • Otsuka America Pharmaceutical, Inc.$60
  • plus $300 from 14 others

What the payments were for

  • Food & beverage$1,302100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,302 in reported general payments places this provider in the 75th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$27,146
Medicare patients
74
Services billed
252

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide27$32,113
PremarinEstrogens, Conjugated12$2,393
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen62$857
Albuterol Sulfate HfaAlbuterol Sulfate14$372
Diltiazem 24hr Er (Cd)Diltiazem Hcl17$213
Atorvastatin Calcium32$197
Morphine Sulfate ErMorphine Sulfate11$181
Clonazepam19$152
Levothyroxine Sodium15$145
Lisinopril35$141
Pantoprazole Sodium13$118
Ondansetron OdtOndansetron11$104
Fluoxetine Hcl16$94
Ciprofloxacin Hcl11$63
Simvastatin12$58

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$34$32,11327 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Marion

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →